Description
Cardiogen is a synthetic bioregulator tetrapeptide (H-Ala-Glu-Asp-Arg-OH) designed to support cardiovascular health and cellular resilience. By penetrating cell membranes, it is studied for its ability to regulate gene expression, support cardiomyocyte survival, and promote tissue repair.
Core Mechanisms & Research
Cardiogen functions at the genomic level, rather than through traditional receptor binding, making it an area of interest for cellular longevity:
Cardiomyocyte Proliferation: Research indicates that Cardiogen may stimulate the formation of heart muscle cells and support tissue adaptation.
Apoptosis Regulation: Studies suggest the peptide may reduce the expression of the p53 protein, which could potentially slow programmed cell death (apoptosis) in myocardial tissue.
Fibroblast Modulation: It is theorized to influence fibroblast activity, potentially aiding in tissue repair and managing post-injury scar formation
Disclaimer: CARDIOGEN is not evaluated or approved by the FDA for therapeutic use in the treatment of diseases.
Regulatory Warning: These peptide formulations are strictly designated for laboratory research use only and are not approved for human consumption or general medical prescriptions.





Reviews
There are no reviews yet.